CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $141,571 | +4.0% | 3,119 | +28.7% | 0.11% | +8.0% |
Q2 2023 | $136,083 | +77.0% | 2,424 | +42.6% | 0.10% | +72.4% |
Q1 2023 | $76,891 | +3278.3% | 1,700 | +2935.7% | 0.06% | +2800.0% |
Q4 2022 | $2,276 | +127.6% | 56 | +211.1% | 0.00% | +100.0% |
Q3 2022 | $1,000 | -66.7% | 18 | -66.0% | 0.00% | -50.0% |
Q2 2022 | $3,000 | 0.0% | 53 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $3,000 | +50.0% | 53 | +112.0% | 0.00% | +100.0% |
Q4 2021 | $2,000 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |